D.E. Shaw & Co’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

D.E. Shaw & Co’s Portfolio SSAA Stock Details SSAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-494,534	Closed	-$4.89M	–	5443
2022 Q3	$4.89M	Buy	494,534 +2,561	+0.5%	+$25.2K	0.01%	2123
2022 Q2	$4.83M	Buy	491,973 +69,900	+17%	+$685K	0.01%	2169
2022 Q1	$4.14M	Sell	422,073 -737,399	-64%	-$7.19M	﹤0.01%	2539
2021 Q4	$11.3M	Buy	1,159,472 +896,871	+342%	+$8.77M	0.01%	1550
2021 Q3	$2.55M	Buy	262,601 +80,971	+45%	+$786K	﹤0.01%	2805
2021 Q2	$1.76M	Buy	+181,630	New	+$1.78M	﹤0.01%	3074

D.E. Shaw & Co's SSAA Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 494,534 shares — an estimated $4.89M sold.

D.E. Shaw & Co first reported a position in SSAA in Q2 2021 and held it in 6 quarters. The position peaked at $11.3M in Q4 2021. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

D.E. Shaw & Co reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
D.E. Shaw & Co sold 494,534 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $4.89M.
D.E. Shaw & Co first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q2 2021 and held it in 6 quarters.
D.E. Shaw & Co's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $11.3M in Q4 2021.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.